6 reports

Figure ##. ##.

  • Cholesterol
  • World
  • Forecast
  • Market Size
  • Bio-Rad Laboratories, Inc.
  • Risk Factors and Comorbidities for Dyslipidemia

PLOS ONE; ##(##): ##-##.

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company
  • Risk Factors and Comorbidities for Dyslipidemia

Plos One; ##(##): ##-##.

  • Cholesterol
  • China
  • Germany
  • United States
  • Forecast
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cholesterol
  • Clinical Trial
  • Lipid Modifying Drug
  • Pharmaceutical
  • World

Hoffmann-La Roche Ltd Galmed Pharmaceuticals Ltd Gemphire Therapeutics Inc GemVax & KAEL Co Ltd Guangdong Zhongsheng Pharmaceutical Co Ltd Hanmi Pharmaceuticals Co Ltd Huons Global Co Ltd Inorbit Therapeutics AB Immuron Ltd Inventiva ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Cholesterol
  • Digestive System Disorder
  • Therapy
  • United States
  • Product Initiative
  • DYSLIPIDEMIA - PIPELINE BY HANDOK INC, H2 2018
  • Indication Name

Hyundai Pharma offers ETC products such as minopecia, cotareg, tareg, xilep xl, xilep, alcefin tablets and others in the therapeutic areas of cardio vascular, CNS, digestive system, contraceptives, endocrine and oral diseases.

  • Cholesterol
  • Obesity
  • United States
  • Product Initiative
  • Amarin Corporation plc